Janney Montgomery Scott’s Cidara Therapeutics CDTX Stock Holding History

Janney Montgomery Scott’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,400	Closed	-$751K	–	2789
2025 Q4	$751K	Sell	3,400 -460	-12%	-$74.3K	﹤0.01%	1918
2025 Q3	$370K	Buy	+3,860	New	+$246K	﹤0.01%	2351

Janney Montgomery Scott's CDTX Position: Q1 2026 in Review

Janney Montgomery Scott sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 3,400 shares — an estimated $751K sold.

Janney Montgomery Scott first reported a position in CDTX in Q3 2025 and held it in 2 quarters. The position peaked at $751K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Janney Montgomery Scott reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Janney Montgomery Scott sold 3,400 Cidara Therapeutics shares in Q1 2026, an estimated $751K.
Janney Montgomery Scott first reported a position in Cidara Therapeutics in Q3 2025 and held it in 2 quarters.
Janney Montgomery Scott's Cidara Therapeutics position peaked at $751K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Janney Montgomery Scott's 13F filing for Q1 2026, filed 22 Apr 2026.